Sichenzia Ross Ference LLP以800万美元的私人配售代表AIT Therapeutics

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

The Company issued approximately 1.6 million shares of common stock at a purchase price of $5.00 per share.  The private placement was made directly by the Company without an underwriter or placement agent.

The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Avital Perlman.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP是一家全国知名的证券和公司律师事务所,在涉及证券业的所有事务中提供经验丰富的法律服务。《超级律师》一直认为我们的律师是全国评级最高的证券律师之一。我们的律师专注于为客户提供私募,首次(IPO)和二次公开发行,替代公开发行,准备SEC备案以及在纽约证券交易所(纽约证券交易所),纳斯达克和场外交易市场等主要资本证券交易所上市的建议。此外,我们的诉讼和仲裁律师可以非常熟练的代表客户处理在美国证券交易委员会,美国金融业监管局和其他法庭方面,从常规诉讼到复杂案件的事宜。我们还代表客户处理各种住宅和商业房地产以及信托和遗产事宜。

访问SRF的LinkedIn页面
Sichenzia Ross Ference LLP

Latest posts by Sichenzia Ross Ference LLP (see all)